Low levels of antigenic variability in fluconazole-susceptible and - resistant Candida albicans isolates from human immunodeficiency virus- infected patients with oropharyngeal candidiasis

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 5, 1999, Pages 665-670

  Lopez Ribot, Jose L ^a   McAtee, Robert K ^a   Kirkpatrick, William R ^a   La Valle, Roberto ^b   Patterson, Thomas F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGENIC VARIATION; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

EID: 0032849538     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.5.665-670.1999     Document Type: Article

References (50)

1. Alloush, H. M., J. L. López-Ribot, and W. L. Chaffin. 1996. Dynamic expression of cell wall proteins of Candida albicans revealed by probes from cDNA clones. J. Med. Vet. Mycol. 34:91-97.
2. Angiolella, L., M. Facchin, A. Stringaro, B. Maras, N. Simonetti, and A. Cassone. 1996. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J. Infect. Dis. 173:684-690.
3. Barturen, B., J. Bikandi, R. San Millán, M. D. Moragues, P. Régulez, G. Quindós, and J. Pontón, 1995. Variability in expression of antigens responsible for serotype specificity in Candida albicans. Microbiology 141:1535-1543.
4. Boschman, C. R., U. R. Bodnar, M. A. Tornatore, A. A. Obias, G. A. Noskin, K. Englund, M. A. Postelnick, T. Suriano, and L. R. Peterson. 1998. Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center. Antimicrob. Agents Chemother. 42:734-738.
5. Brawner, D. L., and J. E. Cutler. 1986. Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect. Immun. 51:337-343.
6. Brawner, D. L., J. E. Cutler, and W. L. Beatty. 1990. Caveats in the investigation of form-specific molecules of Candida albicans. Infect. Immun. 58: 378-383.
7. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
8. Casanova, M., M. L. Gil, L. Cardeñoso, J. P. Martínez, and R. Sentandreu. 1989. Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect. Immun. 57:262-271.
9. Casanova, M., J. L. López-Ribot, C. Monteagudo, A. Llombart-Bosch, R. Sentandreu, and J. P. Martínez. 1992. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 60:4221-4229.
10. Cassone, A. 1989. Cell wall of Candida albicans: its functions and its impact on the host. Curr. Top. Med. Mycol. 3:248-314.
11. Chaffin, W. L., J. L. López-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez. 1998. Cell wall proteins of Candida albicans: identity, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
12. Cutler, J. E., and T. Kanbe. 1993. Antigenic variability of Candida albicans cell surface. Curr. Top. Med. Mycol. 5:27-47.
13. De Bernardis, F., A. Molinari, M. Boccanera, A. Stringaro, R. Robert, J. M. Senet, G. Arancia, and A. Cassone. 1994. Modulation of cell surface associated mannoprotein antigen expression in experimental candidal vaginitis. Infect. Immun. 62:509-519.
14. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
15. Franklyn, K. M., J. R. Warmington, A. K. Ott, and R. B. Ashman. 1990. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol. Cell Biol. 68:173-178.
16. Gil, M. L., M. Casanova, J. P. Martínez, and R. Sentandreu. 1991. Antigenic cell wall mannoproteins in Candida albicans isolates and other Candida species. J. Gen. Microbiol. 137:1053-1056.
17. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
18. Hazen, K. C., and B. W. Hazen. 1992. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect. Immun. 60: 1499-1508.
19. Hernando, F. L., J. C. Cailliez, P. A. Trinel, C. Faille, D. W. R. Mackenzie, and D. Poulain. 1993. Qualitative and quantitative differences in recognition patterns of Candida albicans protein and polysaccharide antigens by human sera. J. Med. Vet. Mycol. 31:219-226.
20. Hernando, F. L., J. J. Estevez, M. Cebrian, D. Poulain, and J. Pontón. 1993. Identification of Candida albicans cell wall antigens lost during subculture in synthetic media. J. Med. Vet. Mycol. 31:227-237.
21. Jones, J. M. 1990. Laboratory diagnosis of invasive candidiasis. Clin. Microbiol. Rev. 3:32-45.
22. Klein, R. S., C. A. Harris, C. Butkus Small, B. Moll, M. Lesser, and G. H. Friendland. 1984. Oral candidiasis as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-357.
23. La Valle, R., C. Bromuro, L. Ranucci, H. M. Muller, A. Crisanti, and A. Cassone. 1995. Molecular cloning and expression of a 70-kilodalton heat shock protein of Candida albicans. Infect. Immun. 63:4039-4045.
24. Lee, K. L., M. R. Buckley, and C. Campbell. 1975. An amino acid liquid synthetic medium for development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.
25. López-Ribot, J. L., H. M. Alloush, B. J. Masten, and W. L. Chaffin. 1996. Evidence for presence in the cell wall of Candida albicans of a protein related to the hsp70 family. Infect. Immun. 64:3333-3340.
26. López-Ribot, J. L., M. Casanova, M. L. Gil, and J. P. Martínez. 1996. Common and form-specific cell wall antigens of Candida albicans as released by chemical and enzymatic treatments. Mycopathologia 64:5239-5247.
27. López-Ribot, J. L., and W. L. Chaffin. 1994. Binding of the extracellular matrix component entactin to Candida albicans. Infect. Immun. 62:4564-4571.
28. López-Ribot, J. L., R. K. McAtee, L. N. Lee, W. R. Kirkpatrick, T. C. White, D. Sanglard, and T. F. Patterson. 1998. Distinct patterns of gene expression associated with the development of fluconazole resistance in serial Candida albicans isolates from HIV-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:2932-2937.
29. López-Ribot, J. L., C. Monteagudo, P. Sepúlveda, M. Casanova, and W. L. Chaffin. 1996. Expression of the fibrinogen binding mannoprotein and the laminin receptor of Candida albicans in vitro and in infected tissues. FEMS Microbiol. Lett. 142:117-122.
30. Marot-Lebond, A., R. Robert, J. Aubry, P. Ezcurra, and J. M. Senet. 1993. Identification and immunochemical characterization of a germ tube specific antigen of Candida albicans. FEMS Immunol. Med. Microbiol. 7:175-186.
31. Marr, K. A., T. C. White, J.-A. H. van Burik, and R. A. Bowden. 1997. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. Clin. Infect. Dis. 25:908-910.
32. Martínez, J. P., M. L. Gil, J. L. López-Ribot, and W. L. Chaffin. 1998. Serologic response to cell wall proteins and mannoproteins of Candida albicans. Clin. Microbiol. Rev. 11:121-141.
33. Matthews, R. C. 1994. Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology 140:1505-1511.
34. Matthews, R. C., and J. P. Burnie. 1992. The role of hsp90 in fungal infection. Immunol. Today 13:345-348.
35. Matthews, R. C., and J. P. Burnie. 1996. Antibodies against Candida: potential therapeutics? Trends Microbiol. 4:354-358.
36. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
37. Patterson, T. F., W. R. Kirkpatrick, S. G. Revankar, R. K. McAtee, A. W. Fothergill, D. I. McCarthy, and M. G. Rinaldi. 1996. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 34:3237-3239.
38. Patterson, T. F., S. G. Revankar, W. R. Kirkpatrick, O. Dib, A. W. Fothergill, S. W. Redding, D. A. McGough, and M. G. Rinaldi. 1996. A simple method for detecting fluconazole resistant yeast with chromogenic agar. J. Clin. Microbiol. 34:1794-1797.
39. Pfaller, M. A. 1992. The use of molecular techniques for epidemiologic typing of Candida species. Curr. Top. Med. Mycol. 4:43-63.
40. Pontón, J., and J. M. Jones. 1986. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect. Immun. 53:565-572.
41. Pontón, J., A. Marot-Leblond, P. A. Ezkurra, B. Barturen, R. Robert, and J. M. Senet. 1993. Characterization of Candida albicans cell wall antigens with monoclonal antibodies. Infect. Immun. 61:4842-4847.
42. Poulain, D., V. Hopwood, and A. Vernes. 1985. Antigenic variability of Candida albicans. Crit. Rev. Microbiol. 12:223-270.
43. Quindós, G., J. Pontón, R. Cisterna, and D. W. Mackenzie. 1990. Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 9:178-183.
44. Revankar, S. G., W. R. Kirkpatrick, R. McAtee, O. P. Dib, A. W. Fothergill, S. W. Redding, D. A. McGough, M. G. Rinaldi, and T. F. Patterson. 1996. Detection and significance of fluconazole resistance in oropharyngeal candidiasis. J. Infect. Dis. 174:821-827.
45. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
46. Sundstrom, P. M., and G. R. Aliaga. 1992. Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J. Bacteriol. 174:6789-6799.
47. Sundstrom, P. M., and G. R. Aliaga. 1994. A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase. J. Infect. Dis. 169:452-456.
48. Sundstrom, P. M., J. Jensen, and E. Balish. 1994. Humoral and cellular responses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J. Infect. Dis. 170:390-395.
49. Sundstrom, P. M., M. R. Tam, E. J. Nichols, and G. E. Kenny. 1988. Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Infect. Immun. 56:601-606.
50. Tronchin, G., J. P. Bouchara, and R. Robert. 1989. Dynamic changes of the cell wall surface of Candida albicans associated with germination and adherence. Eur. J. Cell Biol. 50:285-290.